On May 15, 2012, Biocon held a symposium on integrative research in oncology at their research center. Key speakers at the event included the director of the Koch Institute for Integrative Cancer Research, the president of R&D at Biocon, and professors from Harvard Medical School. Panel discussions were held on topics such as translational research with marketed oncology products and personalized cancer treatment approaches.

1. Symposium
Integrative Research In
Oncology
On May 15, 2012

2. Prof. Tyler Jacks, Director, Koch Institute for Integrative Cancer Research, MIT, Cambridge -
lighting the lamp at Biocon Research Centre on May 15, 2012

3. Kiran Mazumdar-Shaw, CMD, Biocon - lighting the lamp at Biocon Research Centre

4. Dr. Shekar Patil, MD, DM, Consultant, HCG - lighting the lamp at Biocon Research Centre

5. Prof. Vikas Sukhatme, MD, PhD Prof. Harvard Medical School, Boston, MA,
lighting the lamp at Biocon Research Centre

6. Dr. Abhijit Barve, President R&D, lighting the lamp at Biocon Research Centre

7. Prof. Tyler Jacks Unveiling the Inaugural Plaque of Auditorium at Biocon Research
Centre, May 15, 2012

8. Kiran Mazumdar-Shaw addressing the august gathering at Biocon Research Centre, on May 15, 2012

9. Prof. Tyler Jacks addressing the august gathering at Biocon Research Centre, on May 15, 2012

10. Prof. Vikas Sukhatme addressing the august gathering at Biocon Research Centre, on May 15, 2012

11. Panel Discussion 1: Translational Research with Marketed Products: Case Study: Nimotuzumab
Panelists: Dr. Shekar Patil, Dr. Amit Rauthan, Dr. Govinda Babu & Dr. Vikram Kekatpure

12. Panel Discussion 2: Personalized Cancer Treatment: Onco-markers, Oncogenomics and beyond
Panelists: Dr. Binay Panda, Dr. Mallick Sundaram, Dr. Vijay Chandru & Dr. Neetu Singh